aTyr Pharma ATYR Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $10.74M-2.8% | $11.06M-51.0% | $22.54M+126% | $9.98M+327% | ||
| $67.94M+11.3% | $61.07M-19.2% | $75.62M+34.6% | $56.17M-46.8% | ||
| $2.24M-24.3% | $2.95M-15.3% | $3.48M+10.1% | $3.17M— | ||
| $677K-91.6% | $8.09M+239% | $2.39M-19.0% | $2.95M-43.5% | ||
| $80.24M-2.1% | $81.95M-20.4% | $102.99M+27.4% | $80.87M-28.8% | ||
| $4.26M-12.1% | $4.85M-12.3% | $5.53M+80.8% | $3.06M+463% | ||
| $5.52M-5.0% | $5.82M-13.5% | $6.73M-7.2% | $7.25M+472% | ||
| $148K+124% | $66K-49.6% | $131K-32.1% | $193K+22.2% | ||
| $93M-4.0% | $96.83M-19.7% | $120.65M+26.0% | $95.79M-17.1% | ||
| $3.89M-10.0% | $4.32M+22.5% | $3.53M+13.6% | $3.11M+201% | ||
| $9.79M+4.2% | $9.39M-18.7% | $11.56M+17.2% | $9.86M+146% | ||
| $630K+16.5% | $541K+8.9% | $497K+88.3% | $264K— | ||
| $836K+17.6% | $711K-14.4% | $831K+31.9% | $630K-35.7% | ||
| $630K+16.5% | $541K+8.9% | $497K+88.3% | $264K— | ||
| $15.15M+1.2% | $14.97M-8.8% | $16.42M+18.4% | $13.86M+131% | ||
| $10.31M-7.5% | $11.14M-9.7% | $12.34M+28.1% | $9.63M+2,320% | ||
| $889K-37.7% | $1.43M-25.8% | $1.93M+51.5% | $1.27M— | ||
| $11.14M-6.0% | $11.86M-12.0% | $13.47M+3.5% | $13.02M+845% | ||
| $259K-70.8% | $887K-37.9% | $1.43M+41.8% | $1.01M— | ||
| —— | —— | —— | —— | ||
| $98K+16.7% | $84K+33.3% | $63K+117% | $29K+3.6% | ||
| $673.55M+11.9% | $602.02M+7.8% | $558.69M+14.1% | $489.5M+1.6% | ||
| -$606.16M-13.9% | -$532.05M-13.7% | -$468.02M-12.1% | -$417.63M-12.2% | ||
| -$8K+80.0% | -$40K+45.9% | -$74K+82.9% | -$433K-64.6% | ||
| -$192K-2.7% | -$187K+0.5% | -$188K-4.4% | -$180K-2.9% | ||
| $67.48M-3.6% | $70.02M-22.8% | $90.66M+26.9% | $71.46M-34.6% | ||
| $93M-4.0% | $96.83M-19.7% | $120.65M+26.0% | $95.79M-17.1% | ||
| $67.94M+11.3% | $61.07M-19.2% | $75.62M+34.6% | $56.17M-46.8% | ||
| $873K-49.7% | $1.74M-28.7% | $2.44M-79.3% | $11.78M+2,607% | ||
| $873K-49.7% | $1.74M-28.7% | $2.44M-79.3% | $11.78M+2,607% | ||
| $148K+124% | $66K-49.6% | $131K-32.1% | $193K+22.2% | ||
| $5.52M-5.0% | $5.82M-13.5% | $6.73M-7.2% | $7.25M+472% | ||
| $5.52M-5.0% | $5.82M-13.5% | $6.73M-7.2% | $7.25M+472% | ||
| $148K+124% | $66K-49.6% | $131K-32.1% | $193K+22.2% | ||
| $5.52M-5.0% | $5.82M-13.5% | $6.73M-7.2% | $7.25M+472% | ||
| $148K+124% | $66K-49.6% | $131K-32.1% | $193K+22.2% | ||
| $9.79M+4.2% | $9.39M-18.7% | $11.56M+17.2% | $9.86M+146% | ||
| $9.79M+4.2% | $9.39M-18.7% | $11.56M+17.2% | $9.86M+146% | ||
| $12.66M-8.4% | $13.82M-13.0% | $15.89M+9.2% | $14.55M+956% | ||
| $98K+16.7% | $84K+33.3% | $63K+117% | $29K+3.6% | ||
| $630K+16.5% | $541K+8.9% | $497K+88.3% | $264K— | ||
| $596K-50.0% | $1.19M-33.3% | $1.79M+43.3% | $1.25M— | ||
| -$192K-2.7% | -$187K+0.5% | -$188K-4.4% | -$180K-2.9% | ||
| $677K-91.6% | $8.09M+239% | $2.39M-19.0% | $2.95M-43.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are aTyr Pharma's total assets?
- aTyr Pharma (ATYR) holds $79.7M in total assets, down 18.1% year over year.
- How much debt does aTyr Pharma have?
- aTyr Pharma carries $12.3M in total debt against $57.9M of shareholders' equity, a debt-to-equity ratio of 0.21.
- How much cash does aTyr Pharma have?
- aTyr Pharma holds $10.0M in cash and equivalents.
- Can aTyr Pharma cover its short-term obligations?
- Its current ratio is 5.78 — current assets exceed current liabilities.
- Where does aTyr Pharma's balance sheet data come from?
- Every line is extracted from aTyr Pharma's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
